Research Paper Volume 14, Issue 23 pp 9715—9729
A risk score for the prognosis prediction of the muscle-invasive bladder cancer patients who received gemcitabine plus cisplatin chemotherapy
Figure 6. Risk score comparison in subsets of the clinical characteristics (gender, age at diagnosis, and AJCC pathological stage).